Cargando…

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery

Detalles Bibliográficos
Autores principales:	Michalska, G, Stanek, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084316/ http://dx.doi.org/10.1186/cc7594

Ejemplares similares

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes
por: Liebl, M, et al.
Publicado: (2007)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Experience of NovoSeven administration in the management of severe haemorrhage following cardiac surgery of nonhaemophilic patients
por: Michalska, G, et al.
Publicado: (2007)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Predictive genetic factors for bleeding in cardiac surgery patients with cardiopulmonary bypass
por: Iribarren Sarrias, J, et al.
Publicado: (2006)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

Recombinant activated factor VII in cardiac surgery – first, do no harm
por: Warren, Oliver J, et al.
Publicado: (2007)

The use of activated recombinant coagulation factor VII in patients undergoing major reconstruction surgery for traumatic fracture pelvis or pelvis and acetabulum: a double-blind, randomised, placebo-controlled trial
por: Raobaikady, R, et al.
Publicado: (2005)

Right coronary artery stenting as treatment of postoperative bleeding after cardiac surgery
por: Alvarez, J Rubio, et al.
Publicado: (2013)

Complement activation and excessive bleeding in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2007)

Thrombosis incidence after recombinant active factor VII administration in paediatric cardiac surgery
por: Tachi, Keitaro, et al.
Publicado: (2019)

Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
por: Spivey, M, et al.
Publicado: (2009)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Could the combination of bleeding time and platelet function predict the perioperative transfusion requirements in cardiac surgery patients?
por: Kataphigioti, M, et al.
Publicado: (2007)

Adequacy of Hemostatic Resuscitation Improves Therapeutic Efficacy of Recombinant Activated Factor VII and Reduces Reexploration Rate for Bleeding in Postoperative Cardiac Surgery Patients with Refractory Hemorrhage
por: Feih, Joel T, et al.
Publicado: (2019)

Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study)
por: Galas, F, et al.
Publicado: (2012)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Endocrine responses to major abdominal surgery
por: Dimopoulou, I, et al.
Publicado: (2005)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

Successful use of recombinant activated factor VII (eptacog alfa, Novoseven®) in a refractory bleeding during pediatric cardiac surgery: a case report
por: Ishihara, Mariko, et al.
Publicado: (2015)

Comparison of bioimpedance and oesophageal Doppler cardiac output monitoring during abdominal aortic surgery
por: Jørgensen, HK, et al.
Publicado: (2012)

Factors related to pain after cardiac surgery
por: O Mendonça, Ana Elza, et al.
Publicado: (2015)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Replacement of albumin after abdominal surgery
por: Mahkovic Hergouth, K, et al.
Publicado: (2007)

Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery
por: Omar, Hesham R., et al.
Publicado: (2015)

P107 Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Extrahepatic Abdominal Surgery: a systematic review and meta-analysis
por: Koh, Amanda, et al.
Publicado: (2021)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_83ct9lgc7sr5lriceiltio36kr